Botanical species · safety record

Satureja montana

The EFSA Compendium of Botanicals holds 26 constituent measurements and 2 adverse-effect records for Satureja montana. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Satureja montana L.

26Constituent measurements

2Safety records

8Cited sources

5Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 5 licensed products naming Satureja montana as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Aerial parts
Essential oil from leaf
Herb top flowering
Leaf
Plante entière

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
(+)-pulegone	Aerial part of plants	Essential oil	—	GC-FID	Resolve DOI
Benzoquinones	Aerial part of plants	Solvent extraction	62 Milligram/kilogram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
D,l-isomenthone	Aerial part of plants	Essential oil	—	GC-FID	Resolve DOI
Eugenol	Aerial part of plants	Solvent extraction	≤ 19.44 Percent	GC-MS	Resolve DOI
Eugenol	Aerial part of plants	Solvent extraction	≥ 8.35 Percent	GC-MS	Resolve DOI
Gallic acid	Aerial part of plants	Solvent extraction	≥ 0.14 Percent	HPLC-DAD	Resolve DOI
Gallic acid	Aerial part of plants	Solvent extraction	≤ 1.93 Percent	HPLC-DAD	Resolve DOI
Indole	Aerial part of plants	Solvent extraction	≤ 3.33 Percent	GC-MS	Resolve DOI
Indole	Aerial part of plants	Solvent extraction	≥ 1.25 Percent	GC-MS	Resolve DOI
Methyl salicylate	Aerial part of plants	Solvent extraction	≤ 0.82 Percent	GC-MS	Resolve DOI
Methyl salicylate	Aerial part of plants	Solvent extraction	≥ 0.67 Percent	GC-MS	Resolve DOI
Myrcene	Unspecified	Essential oil	1.13 Percent	GC-FID	Resolve DOI
P-coumaric acid	Aerial part of plants	Solvent extraction	≤ 0.52 Percent	HPLC-DAD	Resolve DOI
P-coumaric acid	Aerial part of plants	Solvent extraction	≥ 0.22 Percent	HPLC-DAD	Resolve DOI
Salicylates	Aerial part of plants	Solvent extraction	≤ 0.37 Percent	HPLC-DAD	Resolve DOI
Salicylates	Aerial part of plants	Solvent extraction	≥ 0.03 Percent	HPLC-DAD	Resolve DOI
Tannins	Leaves	Drying (dehydration)	14 Percent	Unspecified	Resolve DOI
Thymoquinone	Aerial part of plants	Solvent extraction	1052 Milligram/kilogram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Thymoquinone	Aerial part of plants	Solvent extraction	≥ 27.55 Percent	GC-MS	Resolve DOI
Thymoquinone	Aerial part of plants	Solvent extraction	≤ 32.93 Percent	GC-MS	Resolve DOI
(-)-camphor	Flowering top	Essential oil	1.28 Percent	GC-MS	No resolvable identifier
1,8-cineole	Flowering top	Essential oil	1.32 Percent	GC-MS	No resolvable identifier
Eugenol	Aerial part of plants	Solvent extraction	≥ 0.7 Percent	GC-FID-MS	No resolvable identifier
Eugenol	Aerial part of plants	Solvent extraction	≤ 17.8 Percent	GC-FID-MS	No resolvable identifier
Thymoquinone	Aerial part of plants	Solvent extraction	≤ 56.9 Percent	GC-FID-MS	No resolvable identifier
Thymoquinone	Aerial part of plants	Solvent extraction	≥ 16.8 Percent	GC-FID-MS	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Systemic	Neurologic	Leaves	Essential oil (as part-nature)	Rat (as animal)	Acute toxicity	Resolve DOI
Systemic	Neurologic	Leaves	Essential oil (as part-nature)	Rat (as animal)	Acute toxicity	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Dunkic, Valerija., Radovanovic, Ivana., Bezic, Nada., Vuko, Elma. Glycosidically bound volatile compounds of Satureja montana L., S. cuneifolia Ten., S. subspicata Vis. and endemic S. visianii Sili�c. Advances in biological chemistry, 2015, vol. 5, no. 7, p. 235-238.
Taborsky, Jan., Kunt, Miroslav., Kloucek, Pavel., Lachman, Jaromir., Zeleny, Vaclav., Kokoska, Ladislav. Identification of potential sources of thymoquinone and related compounds in Asteraceae, Cupressaceae, Lamiaceae, and Ranunculaceae families . Central european journal of chemistry, 2012, vol. 10, no. 6, p. 1899-1906. DOI
Mezzoug, Nadya., Idaomar, Mohamed., Baudoux, Dominique., Debauche, Pascal., Liemans, Veronique., Zhiri, Abdesselam. Genotoxicity of some essential oils frequently used in aromatherapy. Advances in bioscience and biotechnology, 2016, vol. 7, no. 2, p. 63-73.
Palavra, A. M. F., Coelho, J. P., Barroso, J. G., Rauter, A. P., Fareleira, J. M. N. A., Mainar, A., Urieta, J. S., Nobre, B. P., Gouveia, L., Mendes, R. L., Cabral, J. M. S., Novais, J. M. Supercritical carbon dioxide extraction of bioactive compounds from microalgae and volatile oils from aromatic plants . Journal of supercritical fluids, 2011, vol. 60, p. 21-27. DOI
Roslon, W., Weglarz, Z. Chemical variability of savory (Satureja) genus in respect of essential oil composition and tannin content. Herba polonica, 2002, vol. 48, no. 4, p. 178-182.
STANIC, G., SAMARZIJA, I. DIURETIC ACTIVITY OF SATUREJA-MONTANA SUBSP MONTANA EXTRACTS AND OIL IN RATS . Phytotherapy research, 1993, vol. 7, no. 5, p. 363-366. DOI
Mastelic, J., Jerkovic, I. Gas chromatography-mass spectrometry analysis of free and glycoconjugated aroma compounds of seasonally collected Satureja montana L. . Food chemistry, 2003, vol. 80, no. 1, p. 135-140. DOI
ZANI, F., MASSIMO, G., BENVENUTI, S., BIANCHI, A., ALBASINI, A., MELEGARI, M., VAMPA, G., BELLOTTI, A., MAZZA, P. STUDIES ON THE GENOTOXIC PROPERTIES OF ESSENTIAL OILS WITH BACILLUS-SUBTILIS REC-ASSAY AND SALMONELLA MICROSOME REVERSION ASSAY. PLANTA MEDICA, 1991, vol. 57, no. 3, p. 237-241. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature